Fundraising FoxYonghua Capital
Venture capitalShanghai · Seed–Series B
Also known as Yonghua
Find your way into Yonghua Capital
Sign up to see every warm intro you have to Yonghua Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Yonghua Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
What they invest in
from 5 of 5 portfolio companiesBiotech ×4Healthtech ×4Medical Devices ×4AI & Machine Learning ×2Deep Tech ×1
HQs:United States×3United Kingdom×1
Investments · 5 tracked
founders shown can be your intro pathBy year:2020 · 12019 · 12018 · 13 dated
Spear Bio develops high-sensitivity immunoassays based on its SPEAR (Successive Proximity Extension Amplification Reaction) technology, which originated from research at the Wyss Institute.
BiotechHealthtechMedical Devices
Feng Xuan(Chief Executive Officer & Co-founder)Peng Yin(Director & Co-Founder)
Co-investorsForesite CapitalMaverick Ventures
Miracor develops PiCSO (Pressure-controlled intermittent Coronary Sinus Occlusion), a therapy used during percutaneous coronary intervention (PCI) to treat acute myocardial infarction patients.
HealthtechMedical Devices
Co-investorsDelta PartnersMing capitalBek VenturesQuest for GrowthSHS Capital
Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)Rob Carson(Chief Executive Officer)inSimona Levi(Chief Legal Officer)in
Co-investorsARCH Venture PartnersNorthpond Ventures6 Dimensions CapitalAlly Bridge GroupApplied VenturesKilonova Capital+3 more
Verseau Therapeutics discovers and develops macrophage-targeting monoclonal antibodies to enhance anti-tumor immune responses in cancer patients.
AI & Machine LearningBiotechHealthtechMedical DevicesAuburndale, US
Bob Langer(Director, Promoter)Dan Anderson(Executive Officer, Director, Promoter)inTatiana NovobrantsevainIgor FeldmaninWalter Capone(Executive Officer)Christine Bunt(Executive Officer, Director)in
Co-investors20/20 HealthCare Partners LLCHighlight Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Frequently asked questions
- How many investments has Yonghua Capital made?
- Yonghua Capital has 5 tracked investments, 1 of which have exited.
- What stage does Yonghua Capital invest at?
- Yonghua Capital invests at the Seed, Series A, Series B stages.
- What sectors does Yonghua Capital focus on?
- Yonghua Capital focuses on Advanced Manufacturing, EdTech, Healthtech.
- Where is Yonghua Capital located?
- Yonghua Capital is headquartered in Shanghai, CN.
Similar investors
Blume Ventures is a seed and pre-Series A investment firm headquartered in Mumbai that focuses on early-stage companies in India.
Insight Partners is an investment firm focused on accelerating revenue and profit growth in software companies, providing capital and operational support through its Insight Onsite team.
Kalaari Capital is an India-focused early-stage venture capital firm that backs founders building technology companies across sectors including deeptech, space, AI, cloud, consumer internet, fintech and healthcare.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Kibo Ventures is a Spanish venture capital firm that backs startups, having served as an early and long-term institutional investor to companies across Spain and Europe.